|
Britain's Vectura collaborates with Janssen in asthma, COPD
Yahoo News LONDON (Reuters) – Vectura Group, a respiratory drugs specialist, will work with Janssen Biotech to develop treatments for asthma and lung disease COPD, it said on Tuesday. The collaboration will kick off with the development of a drug candidate for … Vectura Signs Global Development And Licence Deal With Janssen In Asthma … Vectura links with Janssen on asthma/COPD drug development J&J and Vectura sign asthma/COPD deal |
View full post on asthma – Google News